International Women’s Day: The inspiring women in STEM across Southeast Asia
The STEM (Science, Technology, Engineering, and Mathematics) (STEM) field plays a vital role in shaping a modern world that drives innovation and solves complex global challenges. From revolutionary breakthroughs in medical science to advancements in AI (artificial intelligence), STEM continues to be the catalyst of cross-border innovation and disruption.
Investing in health tech to tackle Indonesia’s greatest challenges
The COVID-19 pandemic has exposed critical gaps in Indonesia’s healthcare infrastructure, revealing structural and systemic shortcomings requiring scalable solutions. Change doesn’t happen overnight, particularly for the healthcare sector, which consists of multiple intertwined industries with strict regulatory oversight. But because the industry is highly regulated, regulations play a huge role in shaping trends.
What’s next in Indonesia’s healthcare landscape: Digital transformation, preventive care, and early detection
The Indonesian healthcare landscape has improved significantly in the past decade. It has strengthened access to funding through the successful rollout of the BPJS Kesehatan, or universal healthcare, and the successful reforms implemented through the Omnibus Law that we will see in the coming years.
East Ventures and NalaGenetics’ commitment to supporting genomic sample analysis at the Biomedical and Genome Science Initiative (BGSi)
East Ventures, a pioneering and leading venture capital (VC) firm in Indonesia and Southeast Asia, has signed a Memorandum of Understanding (MoU) with NalaGenetics, a biotechnology company focused on personalized medicine, diet, and screening. This partnership is aimed to support genomic sample analysis in Indonesia's Biomedical and Genome Science Initiative (BGSi). The ceremonial signing of this MoU took place at the East Ventures booth during the Tech in Asia Conference 2023 and was attended by Budi Gunadi Sadikin, Minister of Health of the Republic of Indonesia.
Genetic testing: Leading the way in preventive care for Southeast Asia
In a region plagued by diseases such as heart disease, stroke, cancer, diabetes and neonatal deaths, NalaGenetics is taking a stand. As a prominent provider of genetic testing solutions, this pioneering company is on a mission to combat these ailments and improve patient outcomes in Southeast Asia.
East Ventures launched a white paper on genomics in collaboration with the Ministry of Health of the Republic of Indonesia
East Ventures today launched a white paper “Genomics: Leapfrogging into the Indonesian healthcare future” in collaboration with the Ministry of Health of the Republic of Indonesia and Redseer Strategy Consultants, to provide a comprehensive understanding of how genomics can improve the healthcare system in Indonesia. This white paper serves as a guide for stakeholders in taking the necessary steps to improve our healthcare system and infrastructure for the future.
Why Indonesia should embrace genomics now
Two of the most critical pain points of Indonesia's healthcare system is the high mortality rates for non-communicable diseases, and high cost of treatment. The solution to this is developing genomics. Genomics technology will allow for early detection and targeted treatment, paving the way ahead to transform our healthcare system.
Indonesian Health System Transformation
On 25 October 2022, East Ventures moderated a Fireside Chat with the Indonesian Minister of Health, Budi G. Sadikin at the Embassy of the Republic of Indonesia in Singapore. The session was attended by Singaporean health sector private players, Indonesian businesses, and the Indonesian diaspora in Singapore.